市場調查報告書
商品編碼
1492375
頸動脈支架市場:按類型、材料和最終用戶分類 - 2024-2030 年全球預測Carotid Stents Market by Type (Balloon-expandable Stents, Self-expanding Stents), Material (Metallic Stents, Polymer Stents), End-user - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
頸動脈支架市場規模預估2023年為5.8822億美元,預估2024年將達6.2098億美元,2030年將達8.7805億美元,複合年成長率為5.88%。
頸動脈支架是一種由金屬網製成的小型管狀裝置。用於醫療程序以確保頸動脈的通暢。對於因動脈壁內斑塊堆積導致狹窄(稱為頸動脈疾病)而面臨中風風險的人來說,該手術至關重要。包括中風在內的心血管疾病的增加增加了對頸動脈支架的需求。醫生和患者越來越傾向於恢復時間較短的微創手術,這推動了頸動脈支架的需求和市場成長。與支架置入術相關的風險和併發症正在阻礙頸動脈支架市場的成長。支架置入術技術的進步,包括更安全、更有效的頸動脈支架材料和設計,預計將為市場成長創造機會。
主要市場統計 | |
---|---|
基準年[2023] | 5.8822 億美元 |
預測年份 [2024] | 62098萬美元 |
預測年份 [2030] | 87805萬美元 |
複合年成長率(%) | 5.88% |
區域洞察
由於對中風預防的高度認知和先進的醫療基礎設施,美洲對頸動脈支架的需求強勁。該市場也受到與文明病(例如導致心血管疾病的肥胖和糖尿病)的流行所推動。此外,有利的報銷政策和正在進行的提高頸動脈支架療效和安全性的臨床試驗正在支持該市場的成長。亞太地區頸動脈支架市場正在快速成長。促成這一成長的因素包括醫療基礎設施的改善、醫療保健支出的增加以及對心血管健康相關疾病的認知提高。中國和印度等人口眾多的國家正開始改善醫療服務的可近性。歐洲因其完善的醫療保健系統和高度的預防醫學意識而成為頸動脈支架的領先地區。強大的法律規範和領先醫療保健公司的存在也有助於市場的穩定成長。中東和非洲擁有多樣化的醫療保健管道和多樣化的市場。富裕的海灣國家正在增加對醫療基礎設施的投資,為市場成長提供了潛力。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在頸動脈支架市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對頸動脈支架市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析也為該領域的競爭性質提供了寶貴的見解,包括累積研究期、片段化優勢和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對頸動脈支架市場目前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[191 Pages Report] The Carotid Stents Market size was estimated at USD 588.22 million in 2023 and expected to reach USD 620.98 million in 2024, at a CAGR 5.88% to reach USD 878.05 million by 2030.
Carotid stents are small, tube-shaped devices made of metal mesh. They are used in a medical procedure to ensure the carotid arteries remain open. This procedure is essential for individuals at risk of stroke due to the narrowing caused by plaque buildup inside the artery walls, a condition known as carotid artery disease. Increasing inccidences of cardiovascular diseases, including heart strokes, are drivng the need for carotid stents. The growing inclination towards minimally invasive surgeries among doctors and patients that involve shorter recovery time is driving the need for carotid stents and driving market growth. Risks and complications associated with stenting procedures hamper the growth of the carotid stents market. Rising improvements in stenting technology, including the materials and design of carotid stents that make them safer and more effective, are expected to create opportunities for market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 588.22 million |
Estimated Year [2024] | USD 620.98 million |
Forecast Year [2030] | USD 878.05 million |
CAGR (%) | 5.88% |
Regional Insights
Americas shows a robust demand for carotid stents due to high awareness of stroke prevention and advanced healthcare infrastructure. The prevalence of lifestyle-related diseases such as obesity and diabetes, which contribute to cardiovascular disorders, also boosts the market. Furthermore, favorable reimbursement policies and ongoing clinical trials to improve the efficacy and safety of carotid stents support growth in this market. The APAC region is experiencing rapid growth in the carotid stents market. Factors contributing to this growth include improving health infrastructure, increasing spending on healthcare, and raising awareness of diseases related to cardiovascular health. Countries including, China and India have large populations beginning to have better access to healthcare services. Europe is a major region for carotid stents due to well-established healthcare systems and high awareness about preventative healthcare. The strong regulatory framework and the presence of leading healthcare companies also contribute to steady market growth. The Middle East and Africa have a diverse market with varying access to healthcare. The wealthier Gulf countries show potential for market growth due to increasing investment in health infrastructure.
Market Insights
The market dynamics represent an ever-changing landscape of the Carotid Stents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Carotid Stents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Carotid Stents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Silk Road Medical Launches Advanced Carotid Stent System in the U.S.
Silk Road Medical, Inc. introduced the Tapered ENROUTE Transcarotid Stent System to U.S. hospitals. This advancement builds on the existing ENROUTE system, featuring new configurations to better align with individual patient anatomies. The system supports the Transcarotid Artery Revascularization (TCAR) procedure, a minimally invasive approach designed to significantly enhance stroke protection while reducing complications. This launch marks a significant step in customized, patient-centered stroke intervention strategies. [Published On: 2024-03-05]
Expanded Medicare Coverage Facilitates Access to Cordis Carotid Stents
Cordis endorsed a new policy by the Centers for Medicare & Medicaid Services (CMS) that extends coverage for minimally invasive carotid artery treatments. This decision enhances patient access to the Precise Pro Rx carotid stent system, developed by Cordis for endovascular carotid therapy. The company commended the medical community for effectively demonstrating the benefits of carotid artery stenting (CAS), underlying its commitment to supporting advancements in cardiovascular health management. [Published On: 2023-10-16]
Breakthrough in Stroke Prevention: Introduction of CGuard Prime by InspireMD
InspireMD, Inc., successfully treated the first patient suffering from carotid artery disease with its innovative CGuard Prime stent. This procedure is part of the company's CGuardians U.S. IDE trial. CGuard Prime represents InspireMD's latest advancement in carotid artery stenting (CAS) technology, showcasing ongoing efforts to enhance stroke prevention strategies. [Published On: 2023-05-01]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Carotid Stents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Carotid Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun SE, Balton Sp. z o. o., Becton, Dickinson and Company, Biotronik SE & Co KG, Boston Scientific Corporation, Cardinal Health, Inc., Contego Medical, Inc., Cook Group Incorporated, InspireMD Inc., Medtronic PLC, MicroPort Scientific Corporation, Silk Road Medical, Inc., Stryker Corporation, W. L. Gore & Associates, Inc., and Zhejiang Barty Medical Technology Co., Ltd..
Market Segmentation & Coverage